Inflammatory bowel disease: elevated ANCA or ASCA helped
diagnose it in children
|
|
|
Clinical bottom line (level 1b)
- 40% of children with suspected inflammatory bowel
disease had it.
- The following made inflammatory bowel disease more
likely:
- elevated ASCA or ANCA: (LR + 13)
- weight loss and/or short stature: (LR + 4.3)
- No diarrhoea made inflammatory bowel disease less likely
(LR - 0.18) .
| |
Dubinsky et al: Am J Gastroenterol 2001; 96 : 758-765
|
Expires May 2004 |
The study Setting: paediatric gastroenterology service, university
hospital, Canada
128 patients (aged 4 to 19; median 12, 54%
female) with suspected inflammatory bowel disease
Independent
blinded reference standard, applied in all patients from a consecutive
appropriate spectrum. Reference standard:
- colonoscopy with biopsies and upper GI series with small bowel
follow-through
Diagnostic test: serological blood tests
- ANCA
- pANCA
- ASCA: anti-Saccharomyces cerevisiae antibodies
The evidence pre-test probability of Inflammatory bowel disease:
42%, (95% CI: 34% to 51%)
| diagnostic test |
IBD |
not IBD |
LR+ (95% CI) |
post-test probability |
LR- (95% CI) |
post-test probability |
| family history of IBD (first or second degree relative) |
28 |
16 |
2.4 (1.4 to 4.0) |
64% |
0.61 (0.45 to 0.83) |
31% |
| diarrhoea |
48 |
28 |
2.3 (1.7 to 3.2) |
63% |
0.18 (0.082 to 0.39) |
12% |
| weight loss and/or short stature |
22 |
7 |
4.3 (2.0 to 9.3) |
76% |
0.65 (0.52 to 0.83) |
32% |
| ASCA IgA > 20 or IgG > 40 EU/ml, or ANCA > mean 20
EU/ml |
37 |
4 |
13 (4.8 to 33) |
90% |
0.33 (0.22 to 0.50) |
20% |
| ASCA IgA > 12, IgG > 60 or ANCA > 14 EU/ml |
44 |
21 |
2.9 (2.0 to 4.2) |
68% |
0.26 (0.15 to 0.46) |
16% |
| total |
54 |
74 |
Comments
- Abdominal pain and iron-deficiency anaemia were not clearly
associated with inflammatory bowel disease.
- 87% of childern with inflammatory bowel disease had Crohn's disease.
- 60% of children without inflammatory bowel disease had recurrent
abdominal pain of childhood.
Citation
- Dubinsky MC, Ofman JJ, Urman M, et al: clinical utility of
serodiagnostic testing in suspected pediatric inflammatory bowel
disease. Am J Gastroenterol 2001; 96 : 758-765
Search Terms:
from ACP Journal Club other articles noted Contributor: Chris Ball,
May 2002 Reviewer:
Clinical Question.
| Patient |
children with suspected inflammatory bowel
disease |
| Intervention or Exposure |
clinical features, ANCA, ASCA |
| Outcome |
inflammatory bowel disease | |
|